MedPath

ART-2 Pilot - Driving Pressure Limited Ventilation for Patients With ARDS

Phase 1
Completed
Conditions
Acute Respiratory Distress Syndrome
Interventions
Other: Driving pressure limited ventilation
Other: Conventional ventilation
Registration Number
NCT02365038
Lead Sponsor
Hospital do Coracao
Brief Summary

This is a multicenter randomized controlled pilot trial to investigate the feasibility of a driving pressure limited mechanical ventilation strategy compared to the ARDS Clinical Network strategy (conventional strategy) in patients with acute respiratory distress syndrome (ARDS).

Detailed Description

Mechanical ventilation has the potential to produce or worsen alveolar injury. Driving pressure is the difference between plateau pressure and PEEP. Evidence from observational studies suggests that elevated driving pressure is the main independent determinant of ventilator-induced lung injury, however clinical trials are needed to establish whether targeting low driving pressures can improve clinical outcomes in patients with acute respiratory distress syndrome (ARDS). Thus, ART2pilot is a multicenter randomized controlled trial to assess the feasibility of a driving pressure limited mechanical ventilation strategy compared to the ARDS Clinical Network strategy (conventional strategy) in patients with ARDS. Patients considered to this trial are those in mechanical ventilation with diagnosis of ARDS of less than 72 hours duration. We will exclude patients with less than 18 years old; contraindication to hypercapnia such as intracranial hypertension or recent acute coronary syndrome; patients in which a high probability of death within 24 hours is anticipated and patients under exclusive palliative care. Eligible patients will be randomized to the driving pressure limited ventilation strategy or ARDSNet strategy. The primary outcome is driving pressure between days 1 and 3.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Driving pressure limited ventilationDriving pressure limited ventilationDriving pressure limited ventilation
Conventional ventilationConventional ventilationMechanical ventilation as proposed in the ARDSNet protocol.
Primary Outcome Measures
NameTimeMethod
Mean driving pressure between day 1 and day 3Day 1 to Day 3 after randomization

Driving pressure is the difference between plateau pressure and PEEP. It will be measured every morning in patients without spontaneous efforts. As every patients will have up to three measurements, we will consider the mean driving pressure for each patient.

Secondary Outcome Measures
NameTimeMethod
In-hospital mortalityHospital stay
Adherence to study procedures: daily adjustement of driving pressure in experimental group and tidal volume in the control groupDays 1 to 7
Mean plateau pressure from day 1 to day 7Days 1 to 7
Mean driving pressure from day 1 to day 7Days 1 to 7
Mean respiratory rate from day 1 to day 7Days 1 to 7
BarotraumaDays 1 to 7
Mean PEEP from day 1 to 7Days 1 to 7
Mean tidal volume from day 1 to day 7Days 1 to 7
Length of stay in hospitalIn-hospital stay
Mechanical ventilation free days from day 0 to day 28From day 0 to day 28
28-day survivalFrom day 0 to day 28
Other adverse eventsDays 1 to 7
Rate of driving pressure equal or lower than 13cmH2ODays 1 to 3 after randomization
Mean static compliance of the respiratory system from day 1 to day 7Days 1 to 7
Severe acidosis (pH <7.1)Days 1 to 7
Length of stay in intensive care unitICU stay
ICU mortalityICU stay
© Copyright 2025. All Rights Reserved by MedPath